Invenomic Capital Management’s FedEx FDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-35,468
Closed -$8.1M 141
2023
Q1
$8.1M Sell
35,468
-8,309
-19% -$1.69M 0.46% 64
2022
Q4
$7.58M Buy
43,777
+35,589
+435% +$5.91M 0.51% 67
2022
Q3
$1.22M Buy
+8,188
New +$1.73M 0.1% 133
2021
Q1
Sell
-1,374
Closed -$356K 131
2020
Q4
$356K Sell
1,374
-2,863
-68% -$793K 0.09% 109
2020
Q3
$1.07M Sell
4,237
-8,882
-68% -$1.78M 0.59% 53
2020
Q2
$1.84M Sell
13,119
-2,174
-14% -$273K 1.36% 19
2020
Q1
$1.85M Buy
15,293
+2,135
+16% +$301K 1.52% 18
2019
Q4
$1.99M Buy
+13,158
New +$2.03M 0.8% 53

Other funds holding FDX

Invenomic Capital Management's FDX Position: Q2 2023 in Review

Invenomic Capital Management sold out of FedEx (FDX) in Q2 2023, closing a stake of 35,468 shares — an estimated $8.1M sold.

Invenomic Capital Management first reported a position in FDX in Q4 2019 and held it in 8 quarters. The position peaked at $8.1M in Q1 2023. 1,667 funds tracked by Wall St. Rank hold FDX as of Q2 2023.

  • Invenomic Capital Management reported no remaining FedEx position as of Q2 2023 after selling out during the quarter.
  • Invenomic Capital Management sold 35,468 FedEx shares in Q2 2023, an estimated $8.1M.
  • Invenomic Capital Management first reported a position in FedEx in Q4 2019 and held it in 8 quarters.
  • Invenomic Capital Management's FedEx position peaked at $8.1M in Q1 2023.
  • 1,667 funds tracked by Wall St. Rank held FedEx as of Q2 2023.

Based on Invenomic Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.